The Effect of Age and Recent Influenza Vaccination History on the Immunogenicity and Efficacy of 2009-10 Seasonal Trivalent Inactivated Influenza Vaccination in Children

被引:36
|
作者
Ng, Sophia [1 ]
Ip, Dennis K. M. [1 ]
Fang, Vicky J. [1 ]
Chan, Kwok-Hung [2 ]
Chiu, Susan S. [3 ]
Leung, Gabriel M. [1 ]
Peiris, J. S. Malik [1 ,4 ]
Cowling, Benjamin J. [1 ]
机构
[1] Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China
[2] Univ Hong Kong, Li Ka Shing Fac Med, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China
[3] Univ Hong Kong, Li Ka Shing Fac Med, Dept Pediat & Adolescent Med, Hong Kong, Hong Kong, Peoples R China
[4] Univ Hong Kong, Li Ka Shing Fac Med, Influenza Res Ctr, Hong Kong, Hong Kong, Peoples R China
来源
PLOS ONE | 2013年 / 8卷 / 03期
关键词
ANTIBODY-RESPONSES; PANDEMIC INFLUENZA; PROTECTIVE EFFICACY; ANNUAL IMMUNIZATION; IMMUNE-RESPONSE; VIRUS; STRAINS; YOUNG; VACCINES;
D O I
10.1371/journal.pone.0059077
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: There is some evidence that annual vaccination of trivalent inactivated influenza vaccine (TIV) may lead to reduced vaccine immunogenicity but evidence is lacking on whether vaccine efficacy is affected by prior vaccination history. The efficacy of one dose of TIV in children 6-8 y of age against influenza B is uncertain. We examined whether immunogenicity and efficacy of influenza vaccination in school-age children varied by age and past vaccination history. Methods and Findings: We conducted a randomized controlled trial of 2009-10 TIV. Influenza vaccination history in the two preceding years was recorded. Immunogenicity was assessed by comparison of HI titers before and one month after receipt of TIV/placebo. Subjects were followed up for 11 months with symptom diaries, and respiratory specimens were collected during acute respiratory illnesses to permit confirmation of influenza virus infections. We found that previous vaccination was associated with reduced antibody responses to TIV against seasonal A(H1N1) and A(H3N2) particularly in children 9-17 y of age, but increased antibody responses to the same lineage of influenza B virus in children 6-8 y of age. Serological responses to the influenza A vaccine viruses were high regardless of vaccination history. One dose of TIV appeared to be efficacious against confirmed influenza B in children 6-8 y of age regardless of vaccination history. Conclusions: Prior vaccination was associated with lower antibody titer rises following vaccination against seasonal influenza A vaccine viruses, but higher responses to influenza B among individuals primed with viruses from the same lineage in preceding years. In a year in which influenza B virus predominated, no impact of prior vaccination history was observed on vaccine efficacy against influenza B. The strains that circulated in the year of study did not allow us to study the effect of prior vaccination on vaccine efficacy against influenza A.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Immunogenicity of Trivalent Inactivated Influenza Vaccination Received During Pregnancy or Postpartum
    Sperling, Rhoda S.
    Engel, Stephanie M.
    Wallenstein, Sylvan
    Kraus, Thomas A.
    Garrido, Jose
    Singh, Tricia
    Kellerman, Lisa
    Moran, Thomas M.
    OBSTETRICS AND GYNECOLOGY, 2012, 119 (03): : 631 - 639
  • [2] Seasonal Influenza Vaccination Coverage - United States, 2009-10 and 2010-11
    McIntyre, Anne F.
    Gonzalez-Feliciano, Amparo G.
    Bryan, Leah N.
    Santibanez, Tammy A.
    Williams, Walter W.
    Singleton, James A.
    MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2013, 62 (03): : 65 - 68
  • [3] Influenza vaccination in adults with asthma: Safety of an inactivated trivalent influenza vaccine
    Kmiecik, T.
    Arnoux, Sabine
    Kobryn, Aleksandra
    Gorski, Pawel
    JOURNAL OF ASTHMA, 2007, 44 (10) : 817 - 822
  • [4] Immunogenicity and protective efficacy of influenza vaccination
    Hannoun, C
    Megas, F
    Piercy, J
    VIRUS RESEARCH, 2004, 103 (1-2) : 133 - 138
  • [5] Seasonal Influenza Vaccination and the 2009 Pandemic
    Mercer, Geoffry
    Kelly, Heath
    CLINICAL INFECTIOUS DISEASES, 2011, 52 (06) : 828 - 829
  • [6] Safety and efficacy of trivalent inactivated influenza vaccine in young children: a summary for the new era of routine vaccination
    Zangwill, KM
    Belshe, RB
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2004, 23 (03) : 189 - 200
  • [7] The effect of smoking on influenza, influenza vaccination efficacy and on the antibody response to influenza vaccination
    Cruijff, M
    Thijs, C
    Govaert, T
    Aretz, K
    Dinant, GJ
    Knottnerus, A
    VACCINE, 1999, 17 (05) : 426 - 432
  • [8] Immunogenicity and clinical efficacy of influenza vaccination in pregnancy
    Kay, Alexander W.
    Blish, Catherine A.
    FRONTIERS IN IMMUNOLOGY, 2015, 6 : 1 - 9
  • [9] Safety and immunogenicity of seasonal trivalent inactivated influenza vaccines in pregnant women
    Munoz, Flor M.
    Jackson, Lisa A.
    Swamy, Geeta K.
    Edwards, Kathryn M.
    Frey, Sharon E.
    Stephens, Ina
    Ault, Kevin
    Winokur, Patricia
    Petrie, Carey R.
    Wolff, Mark
    Patel, Shital M.
    Keitel, Wendy A.
    VACCINE, 2018, 36 (52) : 8054 - 8061
  • [10] The Safety and Immunogenicity of Trivalent Inactivated Influenza Vaccination: A Study of Maternal-Cord Blood Pairs in Taiwan
    Lin, Shin-Yu
    Wu, En-Tzu
    Lin, Chia-Hui
    Shyu, Ming-Kwang
    Lee, Chien-Nan
    PLOS ONE, 2013, 8 (06):